BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma XH, Wang S, Liu SY, Chen K, Wu ZY, Li DF, Mi YT, Hu LB, Chen ZW, Zhao XM. Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World J Gastroenterol 2019; 25(24): 3030-3043 [PMID: 31293339 DOI: 10.3748/wjg.v25.i24.3030]
URL: https://www.wjgnet.com/1948-5182/full/v25/i24/3030.htm
Number Citing Articles
1
Rebeca Escutia-Gutiérrez, Ana Sandoval-Rodríguez, Adalberto Zamudio-Ojeda, Santiago José Guevara-Martínez, Juan Armendáriz-Borunda. Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular CarcinomaJournal of Clinical Medicine 2023; 12(21): 6867 doi: 10.3390/jcm12216867
2
Yufei Zhang, Xiaoxiong Wu, Hongfan Zhu, Yun Cong. Development and in functional study of a bi-specific sustained release drug-loaded nano-liposomes for hepatocellular carcinomaJournal of Biomaterials Applications 2023; 38(1): 97 doi: 10.1177/08853282231179313
3
Yi-Ming Qi, En-Hua Xiao. Advances in application of novel magnetic resonance imaging technologies in liver disease diagnosisWorld Journal of Gastroenterology 2023; 29(28): 4384-4396 doi: 10.3748/wjg.v29.i28.4384
4
Xiao-Hong Ma, Kun Chen, Shuang Wang, Si-Yun Liu, Deng-Feng Li, Yong-Tao Mi, Zhi-Yuan Wu, Chun-Feng Qu, Xin-Ming Zhao. Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse modelWorld Journal of Gastrointestinal Oncology 2022; 14(4): 858-871 doi: 10.4251/wjgo.v14.i4.858
5
Alessia Peserico, Chiara Di Berardino, Valentina Russo, Giulia Capacchietti, Oriana Di Giacinto, Angelo Canciello, Chiara Camerano Spelta Rapini, Barbara Barboni. Nanotechnology-Assisted Cell TrackingNanomaterials 2022; 12(9): 1414 doi: 10.3390/nano12091414
6
Bin Yi, Tian Wu, Nan Zhu, Yao Huang, Xiaoyu Yang, Lei Yuan, Yingjun Wu, Xiaofei Liang, Xiaoqing Jiang. The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinomaJournal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00818-3
7
Weiyi Wang, Chao Wei. Advances in the early diagnosis of hepatocellular carcinomaGenes & Diseases 2020; 7(3): 308 doi: 10.1016/j.gendis.2020.01.014
8
Florin Graur, Aida Puia, Emil Ioan Mois, Septimiu Moldovan, Alexandra Pusta, Cecilia Cristea, Simona Cavalu, Cosmin Puia, Nadim Al Hajjar. Nanotechnology in the Diagnostic and Therapy of Hepatocellular CarcinomaMaterials 2022; 15(11): 3893 doi: 10.3390/ma15113893
9
Dongxu Zhao, Jian Cao, Lei Zhang, Shaohua Zhang, Song Wu. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and TreatmentBiosensors 2022; 12(5): 342 doi: 10.3390/bios12050342
10
Yuyan Guo, Shuang Shao, Ruinan Gu, Xiubo Hu, Man Zhao, Yanbo Peng, Wenyuan Zhang, Beining Zhang, Jiaxin Ding, Na Wang, Haisheng Peng, Jinxia Han. Application of nanomaterials in early diagnosis of cancerNanotechnology Reviews 2023; 12(1) doi: 10.1515/ntrev-2023-0116
11
Yan Song, Yue-yue Zhang, Qin Yu, Tong Chen, Chao-gang Wei, Rui Zhang, Wei Hu, Xu-jun Qian, Zhi Zhu, Xue-wu Zhang, Jun-kang Shen. A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1123141
12
Yinghua Wu, Junfeng Zhang, Wen He, Chenchen Li, Yanli Wang. Nanomaterials for Targeting Liver Disease: Research Progress and Future PerspectivesNano Biomedicine and Engineering 2023; 15(2): 199 doi: 10.26599/NBE.2023.9290024
13
Zi−Li Huang, Feng Li, Jun−Tao Zhang, Xiang−Jun Shi, Yong−Hua Xu, Xiu−Yan Huang. Research on the Construction of Bispecific-Targeted Sustained-Release Drug-Delivery Microspheres and Their Function in Treatment of Hepatocellular CarcinomaACS Omega 2022; 7(25): 22003 doi: 10.1021/acsomega.2c02584
14
Yidi Chen, Yun Qin, Yuanan Wu, Hong Wei, Yi Wei, Zhen Zhang, Ting Duan, Hanyu Jiang, Bin Song. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imagingFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.973153
15
Deepak Kukkar, Preeti Kukkar, Vanish Kumar, Jongki Hong, Ki-Hyun Kim, Akash Deep. Recent advances in nanoscale materials for antibody-based cancer theranosticsBiosensors and Bioelectronics 2021; 173: 112787 doi: 10.1016/j.bios.2020.112787
16
Han Wu, Ming‐Da Wang, Lei Liang, Hao Xing, Cheng‐Wu Zhang, Feng Shen, Dong‐Sheng Huang, Tian Yang. Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to ManagementSmall 2021; 17(6) doi: 10.1002/smll.202005236
17
Huanhuan Chong, Yuda Gong, Yunfei Zhang, Yongming Dai, Ruofan Sheng, Mengsu Zeng. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative RecurrenceAcademic Radiology 2023; 30(1): 49 doi: 10.1016/j.acra.2022.04.006
18
Yin Zongyi, Li Xiaowu. Immunotherapy for hepatocellular carcinomaCancer Letters 2020; 470: 8 doi: 10.1016/j.canlet.2019.12.002
19
Tingting Liu, Li Liu, Li Li, Jing Cai. Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinomaMaterials Today Bio 2023; 22: 100766 doi: 10.1016/j.mtbio.2023.100766
20
Tayebe Sobhani, Daryoush Shahbazi-Gahrouei, Maryam Zahraei, Seyed Hossein Hejazi, Fatemeh Dousti, Mahboubeh Rostami. Novel MR imaging nanoprobe for hepatocellular carcinoma detection based on manganese–zinc ferrite nanoparticles: in vitro and in vivo assessmentsJournal of Cancer Research and Clinical Oncology 2023; 149(8): 4939 doi: 10.1007/s00432-022-04427-x